Viimane versioon :
08/05/2024
Infostab
Ingredientide nimekiri
Nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
Uurimisrühmad
Valistab
Plakat
Sidemed
Sponsorid
Autor
Kasutusjuhend
Ajakiri
Pentamidine isetionate
Keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
DBL Pentamidine isetionate
Malaisia
Manicare
Argentiina
Nebupent
Ameerika ühendriigid
Pentacarinat
Austria, Belgia, Hispaania, Holland, Itaalia, Kolumbia, Kreeka, Luksemburg, Prantsusmaa, Rootsi, Saksamaa, Soome, Suurbritannia, Sveits, Taani, Uus-Meremaa
Pentam
Ameerika ühendriigid
Pentamidina
Argentiina, Hispaania
Pentamidine isethionate
Ameerika ühendriigid, Austraalia, Kanada, Malaisia
Pentamina
Portugal
Viited : Pentamidine isetionate
Tüüp
Avaldamine
36
Ajaleht
Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73
Ajaleht
Lor E, Takagi J.
Visual compatibility of foscarnet with other injectable drugs.
Am J Hosp Pharm 1990 ; 47: 157-159.
198
Ajaleht
Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
275
Ajaleht
Lewis JD, El-Gendy A.
Cephalosporin-pentamidine isethionate incompatibilities.
Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337
Ajaleht
Bashaw ED, Amantea MA, Minor JR, Galleli JF.
Visual compatibility of zidovudine with other drugs during simulated Y-site administration.
Am J Hosp Pharm 1988 ; 45: 2532-2533.
424
Ajaleht
De NC, Alam AS, Kapoor JN.
Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections.
Am J Hosp Pharm 1986 ; 43: 1486-1488.
496
Ajaleht
Lor E, Sheybani T, Takagi J.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1991 ; 48: 744-746.
604
Labor
Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
1135
Ajaleht
Baltz JK, Kennedy P, Minor JR, Gallelli J.
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235
Ajaleht
Leigh PH, Buddle GC.
Pentamidine infusion stability.
Br J Pharm Pract 1988 ; 10: 22-23.
1625
Ajaleht
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1925
Ajaleht
Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
3543
Labor
Ceftazidime – Summary of Product Characteristics
Wockhardt 2013
3559
Labor
Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2013
3560
Labor
Linezolid (Zyvox®) - Summary of Product Characteristics
Pharmacia 2013
3662
Labor
Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014
Mentions Légales